Novartis makes concerted push into Israeli biotech startup scene

Nick Paul Taylor

Over the past year, has struck a pair of deals in Israel, snagging an option to buy Gamida Cell and a stake in BioLineRx.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS